| RS2545347457 |
ALPL
|
Health Risk |
Likely pathogenic |
Adult hypophosphatasia, Adult hypophosphatasia |
| RS2545347477 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2545347491 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545347532 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2545347584 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Childhood hypophosphatasia |
| RS2545347691 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2545347747 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2545347818 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2545350150 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2545350189 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2545350546 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545350576 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2545350581 |
ALPL
|
Health Risk |
Pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545351114 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2545351166 |
ALPL
|
Health Risk |
Likely pathogenic |
Infantile hypophosphatasia, Infantile hypophosphatasia |
| RS2545351182 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545351407 |
ALPL
|
Health Risk |
Pathogenic |
Adult hypophosphatasia, Adult hypophosphatasia |
| RS2545351622 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545351691 |
ALPL
|
Health Risk |
Likely pathogenic |
Adult hypophosphatasia, Adult hypophosphatasia |
| RS2545351984 |
ALPL
|
Health Risk |
Pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545358074 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly |
| RS2545364132 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545369227 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2545371984 |
ADGRG1
|
Health Risk |
Pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS2545375332 |
CFI
|
Health Risk |
Pathogenic/Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS2545375580 |
CFI
|
Health Risk |
Likely pathogenic |
— |
| RS2545376269 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545376376 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545376508 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545376707 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545376741 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545377069 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545377387 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545377389 |
CFI
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly |
| RS2545377836 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545379327 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545382640 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis |
| RS2545382762 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545383010 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545383032 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545383308 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545383346 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545383503 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545383573 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545389014 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545389249 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545389271 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545389626 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545389884 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2545389934 |
PRMT7
|
Health Risk |
Pathogenic |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS2545394587 |
ADGRG1
|
Health Risk |
Likely pathogenic |
Bilateral frontoparietal polymicrogyria, Bilateral frontoparietal polymicrogyria |
| RS2545395225 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal myopathy with anterior tibial onset, Miyoshi muscular dystrophy 1 |
| RS2545395376 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545396000 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545396036 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545396065 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545396702 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545396718 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545397244 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545405264 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545405505 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2545406515 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545406592 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545406872 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545407253 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545407375 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545407876 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545409225 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545413054 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545413144 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |
| RS2545414060 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545417186 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545417252 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545417489 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545417716 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545417991 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545418010 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545418182 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2545418342 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545418573 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545418608 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545418630 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2545418704 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545418887 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545418921 |
GUCY2D
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS2545418937 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS2545419645 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545419678 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545419752 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545420079 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2545420133 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545420135 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2545420192 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545420235 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545420239 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS2545420289 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545420396 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2545420447 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2545420928 |
GUCY2D
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS2545421165 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |